Lidocaína B. Braun (Lidocaine Hydrochloride)

Lidocaine works by blocking voltage‑gated sodium channels on nerve membranes, which prevents sodium influx and halts the generation and propagation of action potentials. This interruption of nerve signaling results in a reversible loss of pain perception in the area where the drug is administered.

The exact dose of Lidocaína B. Braun is determined by the prescribing clinician based on factors such as the type of procedure, the route of administration, patient age, weight, liver function and any relevant comorbidities. No standard dose is provided here; the prescriber tailors it to each individual case.

Safety data for Lidocaína B. Braun in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used when the potential benefit justifies any potential risk to the fetus or infant, and under close medical supervision.

To order Lidocaína B. Braun, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with longer‑acting agents such as bupivacaine, lidocaine has a faster onset but a shorter duration of action, making it suitable for procedures that require rapid anesthesia and quicker recovery. Its safety profile is well‑established, though systemic toxicity can occur at high doses, similar to other amide‑type anesthetics.

Lidocaína B. Braun should be stored at ambient temperature, preferably below 25 °C. Keep the vial in its original packaging, protect it from direct light and moisture, and avoid freezing. Ensure the container is tightly sealed when not in use.

Lidocaína B. Braun is administered by qualified healthcare professionals via epidural injection, local infiltration or intradermal injection, depending on the clinical indication. The drug is supplied as a sterile solution for injection and should be prepared and delivered using aseptic technique.

The most serious risks include cardiovascular toxicity such as severe hypotension, arrhythmias or cardiac arrest, and central nervous system effects like seizures. Additionally, rare but life‑threatening allergic reactions (anaphylaxis) may occur. Immediate medical attention is required if any of these symptoms develop.

Lidocaína B. Braun should be avoided in patients with known hypersensitivity to lidocaine or other amide‑type local anesthetics, those with severe heart block or uncontrolled cardiac arrhythmias, and individuals with significant hepatic impairment where drug metabolism may be compromised.